# Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer

> **NCT00004915** · PHASE2 · COMPLETED · sponsor: **Northwestern University**

## Conditions studied

- Endometrial Cancer

## Interventions

- **DRUG:** raloxifene

## Key facts

- **NCT ID:** NCT00004915
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-11
- **Primary completion:** 2000-02
- **Final completion:** 2000-02
- **Target enrollment:** — (—)
- **Last updated:** 2012-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004915, "Raloxifene in Treating Patients With Persistent or Recurrent Endometrial Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00004915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*